Loading...

Nicole Nasholm

Title(s)Specialist, Pediatrics
SchoolSchool of Medicine
Address1550 Fourth St
San Francisco CA 94158
Phone541-953-6505
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Oregon State University, Corvallis, OregonBS03/2010Biology
    University of South Florida, Tampa, FloridaMS01/2016Medical Sciences

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. IMMU-06. INVESTIGATING IMMUNOSUPPRESSIVE MECHANISMS IN THE TUMOR MICROENVIRONMENT OF HIGH-RISK NEUROBLASTOMA; AN IMMUNOCOMPETENT, MYCN-DRIVEN, NON-GERMLINE GEM MODEL. Neuro-Oncology. 2019 Apr 23; 21(Supplement_2):ii94-ii94. Marie Menard, Lauren McHenry, Nicole Nasholm, Shannon Wong-Michalak, Edbert Lu, Erin Simonds, W Clay Gustafson, William A Weiss. .
      View in: Publisher Site   Mentions:
    2. Resistance to Epigenetic-Targeted Therapy Engenders Tumor Cell Vulnerabilities Associated with Enhancer Remodeling. Cancer Cell. 2018 12 10; 34(6):922-938.e7. Iniguez AB, Alexe G, Wang EJ, Roti G, Patel S, Chen L, Kitara S, Conway A, Robichaud AL, Stolte B, Bandopadhayay P, Goodale A, Pantel S, Lee Y, Cheff DM, Hall MD, Guha R, Davis MI, Menard M, Nasholm N, Weiss WA, Qi J, Beroukhim R, Piccioni F, Johannessen C, Stegmaier K. PMID: 30537514.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    3. CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2. J Clin Invest. 2018 01 02; 128(1):446-462. Chen L, Alexe G, Dharia NV, Ross L, Iniguez AB, Conway AS, Wang EJ, Veschi V, Lam N, Qi J, Gustafson WC, Nasholm N, Vazquez F, Weir BA, Cowley GS, Ali LD, Pantel S, Jiang G, Harrington WF, Lee Y, Goodale A, Lubonja R, Krill-Burger JM, Meyers RM, Tsherniak A, Root DE, Bradner JE, Golub TR, Roberts CW, Hahn WC, Weiss WA, Thiele CJ, Stegmaier K. PMID: 29202477.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    4. Phase 1 study of sirolimus in combination with oral cyclophosphamide and topotecan in children and young adults with relapsed and refractory solid tumors. Oncotarget. 2017 Apr 04; 8(14):23851-23861. Vo KT, Karski EE, Nasholm NM, Allen S, Hollinger F, Gustafson WC, Long-Boyle JR, Shiboski S, Matthay KK, DuBois SG. PMID: 27793021.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    5. Absence of STAT1 in donor-derived plasmacytoid dendritic cells results in increased STAT3 and attenuates murine GVHD. Blood. 2014 Sep 18; 124(12):1976-86. Capitini CM, Nasholm NM, Chien CD, Larabee SM, Qin H, Song YK, Klover PJ, Hennighausen L, Khan J, Fry TJ. PMID: 25079358.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    6. Minor antigen distribution predicts site-specific graft-versus-tumor activity of adoptively transferred, minor antigen-specific CD8 T Cells. Biol Blood Marrow Transplant. 2014 Jan; 20(1):26-36. Shand JC, Qin H, Nasholm N, Capitini CM, Fry TJ. PMID: 24141010.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    7. Graft-versus-host disease impairs vaccine responses through decreased CD4+ and CD8+ T cell proliferation and increased perforin-mediated CD8+ T cell apoptosis. J Immunol. 2013 Feb 01; 190(3):1351-9. Capitini CM, Nasholm NM, Duncan BB, Guimond M, Fry TJ. PMID: 23275602.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCellsPHPublic Health
    8. Tissue Distribution of a Minor Antigen, but Not PD-1 Expression, Predicts the Antileukemia Efficacy of Adoptively Transferred, Antigen-Specific T-Cells in a Preclinical Model of Allogeneic Transplant. Blood. 2012 Nov 16; 120(21):456-456. Jessica C. Shand, Christian M. Capitini, Haiying Qin, Nicole Nasholm, Terry J. Fry. .
      View in: Publisher Site   Mentions:
    9. Alloreactivity Directed Against the Widely Distributed HY Antigen Impairs Antitumor Immunity and Results in T-Cell Dysfunction. Blood. 2011 Nov 18; 118(21):2964-2964. Jessica C Shand, Christian M. Capitini, Haiying Qin, Nicole Nasholm, Brynn B Duncan, Terry J Fry. .
      View in: Publisher Site   Mentions:
    10. Extracorporeal photopheresis attenuates murine graft-versus-host disease via bone marrow-derived interleukin-10 and preserves responses to dendritic cell vaccination. Biol Blood Marrow Transplant. 2011 Jun; 17(6):790-9. Capitini CM, Davis JP, Larabee SM, Herby S, Nasholm NM, Fry TJ. PMID: 21216299.
      View in: PubMed   Mentions: 10     Fields:    Translation:AnimalsCellsPHPublic Health
    Nicole's Networks
    Concepts (97)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (7)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _
    ↑